Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma.
BACKGROUND
The aim of the study was to evaluate the association of immunoglobulin G type of autoantibodies to oxidized low-density lipoprotein (oxLDL-lgG) and oxLDL-lgM with the progression of esophageal squamous cell carcinoma (ESSC).


METHODS
Residents from Feicheng, China aged 40 to 69 years were screened for esophageal lesions in a screening program conducted during the period of January 2008 to December 2006. There were 33 controls with normal esophageal squamous epithelium cells, 37 patients with basal cell hyperplasia, 47 with esophageal squamous cell dysplasia, and 43 with ESCC. All the participants were diagnosed by biopsy and histopathological examination. Adiponectin, oxidized low-density lipoprotein (oxLDL), autoantibodies against oxLDL (oxLDL-ab), OxLDL-lgG, and OxLDL-lgM were determined by enzyme linked immunosorbent assay (ELISA). Total cholesterol, High-density lipoprotein (HDL), triglyceride, serum albumin, and blood pressure were co-estimated. Analysis of covariance for lipid levels was used to control the influence of covariates.


RESULTS
The level of oxLDL-lgM increased gradually along with esophageal carcinoma progression. The oxLDL-lgM levels in the ESCC group were the highest after possible covariates were controlled. Binary logistic regression showed that oxLDL-lgM had a positive correlation with the development of esophageal carcinoma, while oxLDL and oxLDL-ab had a negative correlation with ESSC. No significant association between the levels of oxLDL-lgG and adiponectin and the different stages of ESSC was observed.


CONCLUSIONS
The present study shows that the decreased oxLDL and oxLDL-ab and the elevated oxLDL-lgM serum levels may relate to the development and progression of ESSC.
College of Public Health, Shandong University, Jinan, PR China. dyutium@sina.com
Yutao
Y
Diao
Hao
H
Li
Huiqing
H
Li
Yingzhi
Y
Zhou
Qing
Q
Ma
Yan
Y
Wang
Dong
D
Li
D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000453:epidemiology / Q000473:pathology; D002681:China / Q000453:epidemiology; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G; D008055:Lipids / Q000097:blood*; D008077:Lipoproteins, LDL / Q000276:immunology*; D008403:Mass Screening; D008875:Middle Aged
D001323:Autoantibodies; D007074:Immunoglobulin G; D008055:Lipids; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein